Pharma Leaders to Meet Trump in Push to Tweak Drug Policies

The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according to people familiar with the matter, part of an effort to persuade him to scale back some of his predecessor’s policies.

The meeting will include Stephen Ubl, head of Pharmaceutical Research and Manufacturers of America, one of the people said, along with the CEOs of several major drugmakers. The industry is hoping to win the new administration’s support for changes to a law that allows the federal government to negotiate certain drug prices.

Stephen Ubl

Photographer: Andrew Harrer/Bloomberg

The summit comes two days after PhRMA rented ...